NewsBenzingaBionano Genomics: utile per azione del terzo trimestre pari a $(0,54), inferiore alla stima di $(0,51); ricavi a $8,276 milioni, sotto la stima di $8,443 milioni. Bionano Genomics: utile per azione del terzo trimestre pari a $(0,54), inferiore alla stima di $(0,51); ricavi a $8,276 milioni, sotto la stima di $8,443 milioni. Benzinga 2026.11.10 21:12 (GMT+0) Open on Benzinga Other news Apple Reportedly Developing App for Running Local AI Models Probability of a 50 Basis Point Fed Rate Hike in December Is 11.5%, 25 Basis Point Hike Is 88.5% OpenAI Acquires Travel Startup Odessia, Exploring AI Travel Agent Business AI-powered Web3 platform Vision Makers completes $4 million seed round $1000 Invested In Morgan Stanley 10 Years Ago Would Be Worth This Much Today Vericel Corporation 2026 Q3 - Results - Earnings Call Presentation (NASDAQ:VCEL) 2026-11-10
